Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/Dox

Biochemical and Biophysical Research Communications
Chuanxi CaiJianwen Chen

Abstract

Cholesterol is a key lipid in mediating the enzyme activity or signaling pathway of many proteins on the plasma membrane in mammalian cells. In this report, we demonstrate for the first time that after overexpressing caveolin-1, the plasma membrane cholesterol level was decreased by about 12% and 30% for doxorubicin-sensitive and doxorubicin-resistant Hs578T breast cancer cells, respectively. However, the total cholesterol level in both cell lines was increased by about 10%. By measuring fluorescence and flow cytometry using the fluorescence dyes 1,6-diphenyl-1,3,5-hexatriene and Merocyanine 540, we found that overexpressing caveolin-1 resulted in a similar increase in membrane fluidity and loosening of lipid packing density as cholesterol depletion by 1 mM methyl-beta-cyclodextrin (MbetaCD) or 2-hydroxypropyl-beta-cyclodextrin (HbetaCD). Moreover, we found that the transport activity of P-gp was significantly inhibited by 1 mM MbetaCD or HbetaCD, which is also similar to the inhibitory effect of caveolin-1 overexpression. Our data demonstrate for the first time that the reduction of the plasma membrane cholesterol level induced by overexpressing caveolin-1 may indirectly inhibit P-gp transport activity by increasing plasma mem...Continue Reading

References

Jan 1, 1992·Annual Review of Cell Biology·C F Higgins
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·M MurataK Simons
Aug 1, 1993·Current Opinion in Cell Biology·R G Anderson
Nov 7, 1995·Biochemistry·P E Fielding, C J Fielding
Jul 21, 1995·The Journal of Biological Chemistry·E P KilsdonkG H Rothblat
Sep 8, 1995·Science·R G Parton, K Simons
Jun 1, 1993·Immunology Letters·R A SchlegelP Williamson
Dec 1, 1995·Immunology Letters·R F AshmanL L Stunz
Nov 15, 1996·The Journal of Biological Chemistry·E J SmartR G Anderson
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·C J FieldingP E Fielding
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·A BistC J Fielding
Dec 17, 1997·Molecular Biology of the Cell·C HuangS M Mumby
Mar 21, 1998·The Journal of Cell Biology·P ScheiffeleE Ikonen
Aug 17, 1999·Current Opinion in Cell Biology·T V Kurzchalia, R G Parton
Nov 26, 1999·Biochemical Pharmacology·O JonssonK Grankvist
Dec 9, 2000·Biochimica Et Biophysica Acta·C J Fielding, P E Fielding
Nov 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·G SowaW C Sessa
Feb 21, 2002·Biochimica Et Biophysica Acta·Julie JodoinRichard Beliveau
Jul 26, 2002·The Journal of Biological Chemistry·Vimal A PatelAndrey Sorokin
Jul 30, 2002·Proceedings of the National Academy of Sciences of the United States of America·Alexia GarriguesStephane Orlowski
Jul 9, 2004·International Journal of Cancer. Journal International Du Cancer·Chuanxi Cai, Jianwen Chen

❮ Previous
Next ❯

Citations

Sep 14, 2011·Journal of Agricultural and Food Chemistry·Ye ZhangYan-Fei Song
Apr 19, 2011·The Analyst·Sander van den DriescheMichael J Vellekoop
Nov 30, 2011·Antimicrobial Agents and Chemotherapy·Bidyut PurkaitPradeep Das
Aug 21, 2012·International Journal of Nanomedicine·Ye ZhangKe-Ming Lin
Jul 2, 2009·Journal of Biomedical Optics·Céline BoutinRodolphe Jaffiol
Apr 7, 2009·Cancer Letters·Massimo Serra, Katia Scotlandi
Jun 10, 2008·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ferenc FenyvesiMiklós Vecsernyés
May 25, 2005·Fundamental & Clinical Pharmacology·Andrew OwenDavid J Back
Oct 6, 2005·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A PreethaR Banerjee
May 15, 2013·International Journal of Biological Macromolecules·Ye ZhangHeng-Li Jiang
Jul 28, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Wen LiZhe-Sheng Chen
Feb 5, 2016·Scientific Reports·Chih-Yuan LeeJin-Shing Chen
Aug 5, 2017·Cellular Microbiology·Jin Yan LimMark J Walker
Nov 24, 2006·Neurourology and Urodynamics·V CristofaroM P Sullivan
Aug 1, 2008·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Kyung-Nam KimChang-Shin Park
Mar 1, 2006·Electrolyte & Blood Pressure : E & BP·Woon Kyu LeeSeok Ho Cha
Mar 21, 2006·The Journal of Biological Chemistry·Samira Jean-LouisJesse D Martinez
May 22, 2019·Seminars in Cell & Developmental Biology·Tânia CapelôaPierre Sonveaux
Mar 7, 2021·International Journal of Molecular Sciences·Amel Ben SaadThomas Falguières
Jul 20, 2012·Molecular Pharmaceutics·Anett EngelMarkus Keiser
Jun 21, 2014·Molecular Pharmaceutics·Daria Y Alakhova, Alexander V Kabanov
Aug 29, 2019·ACS Omega·Marwan Abdelmahmoud Abdelkarim MakiAbu Bakar Bin Abdul Majeed
Dec 12, 2012·Journal of Proteome Research·Jae-Sung YiYoung-Gyu Ko
Sep 17, 2021·The AAPS Journal·Ruchika BajajDeanna L Kroetz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.